|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 November 2015 |
|
Main ID: |
NCT02257190 |
|
Date of registration:
|
01/10/2014 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
The Features Behind the Beneficial Effects of Interval-walking
aIWS2 |
|
Scientific title:
|
The Features Behind the Beneficial Effects of Interval-walking |
|
Date of first enrolment:
|
October 2014 |
|
Target sample size:
|
12 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02257190 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Denmark
| | | | | | | |
|
Contacts
|
|
Name:
|
Kristian Karstoft, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Centre for Physical Activity Research, Rigshospitalet, Denmark |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Type 2 diabetes mellitus
- Body mass index > 18 but < 40 m2/kg
- Agreement to pause antidiabetic medication from 2 days before to after each trial
Exclusion Criteria:
- Pregnancy
- Smoking
- Use of exogenous insulin
- Contraindication to increased levels of physical activity
- Evidence of thyroid, liver, lung, heart or kidney disease
Age minimum:
30 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Diabetes Mellitus, Type 2
|
|
Intervention(s)
|
|
Behavioral: IW3
|
|
Behavioral: Control
|
|
Behavioral: IW1
|
|
Primary Outcome(s)
|
|
Glycemic control
[Time Frame: Within the first 4 hours after the interventions]
|
|
Secondary Outcome(s)
|
|
Insulin secretion
[Time Frame: Within the first 4 hours after the interventions]
|
|
Insulin sensitivity
[Time Frame: Within the first 4 hours after the interventions]
|
|
Secondary ID(s)
|
|
H-1-2014-060
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|